Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01281293 · ClinicalTrials.gov registry record
Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated
A clinical trial, sponsored by Cyberonics.
- Completed
- Registry status
- 124
- Enrollment target
NCT01281293: Completed study, sponsored by Cyberonics.
NCT01281293 is a clinical trial that has completed, run by Cyberonics. The registered enrollment target is 124 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01281293 has completed, sponsored by Cyberonics.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
Vagus Nerve Stimulation (VNS) Therapy has been approved marked for the treatment of epilepsy since 1994. This post-market study is designed to follow the clinical course and outcomes for patients with refractory seizures treated with adjunctive VNS Therapy. Seizure frequency, seizure severity, side effects burden, depressive symptoms, global impressions, and health care utilization will be evaluated. The results of this study will provide data to guide physicians and their patients in the use of VNS Therapy for patients with refractory seizures who have failed initial trials of anti-epileptic drug (AED) therapy. The data being collected is not for the purposes of confirmatory assessment.
Primary Outcome
To follow the clinical course of patients with refractory seizures treated with adjunctive VNS Therapy over a two-year follow-up period.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2011-01 |
| Est. Completion | 2018-08-16 |
What the finished NCT01281293 record still lists
NCT01281293 is an observational study that tracks outcomes without assigning an intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01281293 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01281293 about?
NCT01281293 is a clinical study titled "Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated". Vagus Nerve Stimulation (VNS) Therapy has been approved marked for the treatment of epilepsy since 1994. This post-market study is designed to follow the clinical course and outcomes for patients with refractory seizures treated with adjunctive VNS Therapy. Seizure frequency, seizure severity, side ...
What is the current status of trial NCT01281293?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2011-01. Estimated completion is 2018-08-16.
Who is sponsoring clinical trial NCT01281293?
This trial is sponsored by Cyberonics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia